Publication Date:
2011-01-29
Description:
We report that, in the rat, administering insulin-like growth factor II (IGF-II, also known as IGF2) significantly enhances memory retention and prevents forgetting. Inhibitory avoidance learning leads to an increase in hippocampal expression of IGF-II, which requires the transcription factor CCAAT enhancer binding protein beta and is essential for memory consolidation. Furthermore, injections of recombinant IGF-II into the hippocampus after either training or memory retrieval significantly enhance memory retention and prevent forgetting. To be effective, IGF-II needs to be administered within a sensitive period of memory consolidation. IGF-II-dependent memory enhancement requires IGF-II receptors, new protein synthesis, the function of activity-regulated cytoskeletal-associated protein and glycogen-synthase kinase 3 (GSK3). Moreover, it correlates with a significant activation of synaptic GSK3beta and increased expression of GluR1 (also known as GRIA1) alpha-amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid receptor subunits. In hippocampal slices, IGF-II promotes IGF-II receptor-dependent, persistent long-term potentiation after weak synaptic stimulation. Thus, IGF-II may represent a novel target for cognitive enhancement therapies.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908455/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉 〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908455/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Chen, Dillon Y -- Stern, Sarah A -- Garcia-Osta, Ana -- Saunier-Rebori, Bernadette -- Pollonini, Gabriella -- Bambah-Mukku, Dhananjay -- Blitzer, Robert D -- Alberini, Cristina M -- F31-MH816213/MH/NIMH NIH HHS/ -- R01 MH065635/MH/NIMH NIH HHS/ -- R01 MH074736/MH/NIMH NIH HHS/ -- R01-GM054508/GM/NIGMS NIH HHS/ -- R01-MH065635/MH/NIMH NIH HHS/ -- R01-MH074736/MH/NIMH NIH HHS/ -- R21-DA29298/DA/NIDA NIH HHS/ -- T32 MH087004/MH/NIMH NIH HHS/ -- T32-MH087004/MH/NIMH NIH HHS/ -- England -- Nature. 2011 Jan 27;469(7331):491-7. doi: 10.1038/nature09667.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Neuroscience, Mount Sinai School of Medicine, New York, New York 10029, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/21270887" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
CCAAT-Enhancer-Binding Protein-beta/metabolism
;
Gene Expression Regulation
;
Hippocampus/drug effects/*metabolism
;
Insulin-Like Growth Factor II/*metabolism/pharmacology
;
Long-Term Potentiation/physiology
;
Male
;
Memory/drug effects/*physiology
;
Rats
;
Rats, Long-Evans
;
Time Factors
Print ISSN:
0028-0836
Electronic ISSN:
1476-4687
Topics:
Biology
,
Chemistry and Pharmacology
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink